Abstract
<p>Supplementary Tables - ST1: Significant siRNA hits identified from the large-scale synthetic lethal siRNA screen combined with SRA737 in A549 cells. ST2: Significant siRNA hits identified from the large-scale synthetic lethal siRNA screen combined with SRA737 in SW620 cells. ST3: CI (exclusive) values for combination treatment with SRA737 plus either aphidicolin, CD437 or gemcitabine in a panel of NSCLC and colorectal cancer cell lines. ST4: Key genetic aberrations in the total panel of NSCLC and colorectal cancer cell lines used. ST5: GI50 values for SRA737, aphidicolin, CD437 and gemcitabine as single agents in the total panel of NSCLC and colorectal cancer cell lines used.</p>
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
